News by Category: Biotech
High Energy / Hazardous Chemistry-based API manufacturing services market
Although hazardous reaction chemistries are not used during early drug development stages owing to the associated risks, they offer a wide range of benefits over traditional approaches.February 18, 2021
Growing at an annualized rate of 12%, the HPAPI and cytotoxic drugs
Manufacturing highly potent drug products is technically and financially demanding; as a result, drug manufacturers are becoming increasingly reliant on contract service providers
February 18, 2021
120 companies across the globe claim to possess the required expertise and infrastructure to offer contract manufacturing services
Development initiatives of HPAPIs and cytotoxic drugs are generally very demanding, both in terms of experience and capital investment.February 18, 2021
115 companies located in various regions across the globe claim to provide contract fill / finish services for various types of biopharmaceutical drug
Despite the fact that biopharmaceuticals offer significant profit margins, innovator companies are plagued by high costs of development, complex production protocols and special procedures and equipment for fill / finish operations.
February 17, 2021
The contract fill / finish services market for biologics market is projected to grow at an annualized rate of ~10%, till 2030
Roots Analysis has done a detailed study on Biologics Fill / Finish Services Market, 2019-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
February 17, 2021
The contract fill / finish services market for biologics is anticipated to be worth USD 4.2 billion by 2030, predicts Roots Analysis
A steadily growing demand for biologic fill / finish services has generated a range of new opportunities for contract service providers; stakeholders have invested heavily to ensure product integrity and safety
February 17, 2021
Fibromyalgia Treatment Market Size and Forecast (2020-2027)
Fibromyalgia is a common and complex chronic pain disorder that causes musculoskeletal pain, fatigue, and localized tenderness affecting individuals mentally, physically, and socially.
February 16, 2021
The antibody contract manufacturing market is projected to reach USD 17 billion by 2030, growing at an annualized rate of 12%, claims Roots Analysis
With over 100 therapeutic monoclonal antibodies and antibody-based products in the market, the demand for developing and manufacturing of such products is anticipated to increase beyond the capabilities of innovator companies alone
February 16, 2021
The diabetes monitoring devices market is estimated to be worth USD 34 billion in 2030, predicts Roots Analysis
The diabetes monitoring devices market is anticipated to witness steady growth, largely driven by the increasing diabetic patient population and the introduction of advanced and cost-effective solutions, in the coming years
February 16, 2021
The diabetes monitoring devices market is projected to grow at a CAGR of 8%, claims Roots Analysis
The anticipated growth in the global diabetic patient population is likely to translate into significant rise in demand for advanced, cost-effective and more patient friendly solutions for disease monitoring
February 16, 2021
Presently, over 240 novel, patient friendly diabetes monitoring devices are available / being developed
Over time, a number of companies have developed advanced variants of the conventional blood glucose monitoring devices, which are portable, and minimally / non-invasive.February 16, 2021
Cell culture biotechnology company Avant launches Zellulin®, the world’s first cell-based functional protein ingredient for skincare
Avant’s first commercialized product answers the call for a sustainable cosmeceutical option and taps into the US$52.5 billion anti-aging products marketFebruary 15, 2021
Global Human Papillomavirus (HPV) Vaccine Market Could Exceed $ Billion By 2027
Human papillomavirus infection is most common sexually transmitted infection caused by HPV-related cancers such as cervical and genital cancer.
February 15, 2021
Cell Analysis Global Market - Forecast to 2027
The cell analysis global market is expected to reach $33,542.0 million by 2027 growing at a mid-single-digit CAGR from 2020 to 2027 due to rising incidence of infectious and non-infectious diseases and demand for early detection, diagnosis
February 11, 2021
Ai vazut folie din sticla iphone
Cumpara folie sticla samsung și folie sticla huawei în Romania, Noi oferim cele mai bune folie sticla huawei și folie din sticla iphone la preturi mici în Romania.
February 9, 2021
Global Sucralose Market
Global Sucralose Market
Global Sucralose Market
Global Sucralose Market
Global Sucralose MarketFebruary 8, 2021
Global CERVICAL CANCER DIAGNOSTIC TEST Market
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade warFebruary 6, 2021
Global Bird Healthcare & Supplements Market
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction.February 3, 2021
Genome Engineering Market Size, Share, Statistics, Trends, Types, Applications, Analysis and Forecast, Global Industry Research 2027
Genome engineering is a process of insertion, deletion, modification or replacement of DNA bases in an organism.
February 3, 2021
Liver Cancer Therapeutics Market To Witness Huge Gains Over 2020-2027
Livercancer is a type of malignant hepatic tumor in or on the liver, which may cause due to excessive alcohol intake, diabetes, certain inherited liver diseases, and hepatitis.
February 2, 2021
Neurofibromatosis Treatment Drug Market Growing Demand and Manufacturing Analysis 2020 to 2027
There are three types of Neurofibromatosis; Neurofibromatosis type 1, Neurofibromatosis type 2, and Schwannomatosis.
February 1, 2021
Anxiety Disorders & Depression Treatments Market to grow at a much faster rate beyond 2020
The anxiety and depression are known to be the most common forms of psychiatric disorders from which a large population is affected across the globe.
January 29, 2021
The “Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2019-2030”
A comparative analysis of the needs of different stakeholders (drug developers, diagnostic developers
January 29, 2021
Presently, close to 50 companies are offering a variety of analytical testing solutions for the assessment of novel cancer biomarkers
Several companies have already developed / are developing analytical tests for novel cancer biomarkers (TMB, MSI / MMR and TILs), intended to assist physicians in making personalized treatment decisions.
January 29, 2021
Cancer biomarkers market for TMB, MSI / MMR and TILs is projected to grow at an annualized rate of ~18%, till 2030
The projected future opportunity is expected to be distributed across different application areas, types of analytical techniques used and various global regions
January 29, 2021
Cancer biomarkers market for TMB, MSI / MMR and TILs is estimated to be worth USD 860 million in 2030, predicts Roots Analysis
A discussion on various steps involved in development operations of companion diagnostics
January 29, 2021
The “Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030"
An analysis of the big biopharma players engaged in this domain, featuring a heat map based on various parameters
January 29, 2021
With two approved drugs and close to 300 clinical / preclinical product candidates,
Several pipeline candidates have recently entered mid to late-stage (phase II and above) trials and are anticipated to enter the market over the next 5-10 years.
January 29, 2021
The bispecific antibody therapeutics market is projected to grow at an annualized rate of ~16%, in the span of 2019 to 2030
The pipeline features drug candidates that target a wide range of biological antigens based on different antibody formats through novel mechanisms of action; more than 50% of these act by retargeting or activation of T-Cells
January 29, 2021
The bispecific antibody therapeutics market is estimated to be worth USD 6.9 billion in 2030, predicts Roots Analysis
An analysis of the initiatives of big biopharma players engaged in this domain.
January 29, 2021
US Cannabis Testing Service Market Seeking Growth from Emerging Markets, Sourcing Strategy and Downstream Buyers To 2027
Development of therapies derived from cannabis and its components has been increasing in the recent past.
January 28, 2021
The Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market (3rd Edition), 2019-2030
An analysis of the various partnerships pertaining to non-invasive cancer diagnostics
January 28, 2021
Nearly 300 non-invasive diagnostic tests, designed for the detection of various types of cancers,
The financial opportunity within the liquid biopsy and other non-invasive cancer diagnostics market has been analyzed across
January 28, 2021
The non-invasive cancer diagnostics market is projected to grow at an annualized rate of ~20%, till 2030
Presently, nearly 300 non-invasive diagnostic tests, designed for the detection of various types of cancers, are either already available in the market or under development across the world
January 28, 2021
The non-invasive cancer diagnostics market is estimated to be worth around USD 20.1 billion by 2030, predicts Roots Analysis
An analysis of the various partnerships pertaining to non-invasive cancer diagnostics, which have been established between 2016 and 2019.
January 28, 2021
The “Human Factors Engineering and Usability Testing Services Market for Medical Devices, 2020-2030”
A detailed discussion on the cost implications across various steps of the HFE and usability testing process.
January 28, 2021
More than 90 companies claim to offer human factors engineering and usability testing services,
Human factors engineering and usability testing have now become an essential part of product design across almost all industries
January 28, 2021
The human factors engineering and usability testing service market is projected to grow at an annualized rate of ~14%, till 2030
Players involved in this domain are steadily expanding their capabilities in order to enhance their respective service portfolios and gain an advantage over competitor firms
January 28, 2021
The human factors engineering and usability testing services market for medical devices is projected
Based on the revenues generated from different services for usability testing, currently, the maximum share is expected to be generated through evaluative testing methodologies (61%), followed by generative testing methodologies (39%).
January 28, 2021
Interferon Beta Drugs Market 2020 Sales, Business Opportunities, Proctuion, Regional Analysis 2027
Interferons are a family of naturally occurring proteins that are produced by eukaryotic cells and mostly show action against viral infections and other biological inducers.January 27, 2021
The “China Biopharmaceutical Contract Manufacturing Market, 2020-2030”
A case study comparing the key characteristics of large molecule and small molecule drugs, along with details on the various steps involved in their respective manufacturing processes
January 27, 2021
Over 35 CMOs / CDMOs in China claim to offer a variety of services related to development and manufacturing of a wide range of biotherapeutic products
In order to meet the growing demand for their services, Chinese CMOs are actively consolidating / expanding their capabilities through partnerships and / or dedicated expansion initiatives
January 27, 2021
The Chines biopharmaceutical contract manufacturing market is projected to grow at an annualized rate of ~13%, till 2030
Big pharma players have also made significant investments in this region, including establishing new facilities, expanding existing R&D centers and growing manufacturing facilities, focused on biotherapeutics
January 27, 2021
The Chinese biopharmaceutical contract manufacturing market is estimated to be worth USD 2.6 billion in 2030
An analysis of the initiatives of big biopharma players engaged in this domain.
January 27, 2021
The “Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2019-2030”
A discussion on the upcoming opportunities (such as development of companion diagnostics, emerging technologies for biomarker assessment, and others) that are likely to impact the evolution of this market over the coming years
January 27, 2021
Presently, close to 50 companies are offering a variety of analytical testing solutions for the assessment of novel cancer biomarkers
Several companies have already developed / are developing analytical tests for novel cancer biomarkers (TMB, MSI / MMR and TILs), intended to assist physicians in making personalized treatment decisions.
January 27, 2021
Cancer biomarkers market for TMB, MSI / MMR and TILs is projected to grow at an annualized rate of ~18%, till 2030
Several novel biomarkers are presently under investigation for a variety of cancer indications; the initiatives of big pharmaceutical companies are indicative of the growing interest in this domain
January 27, 2021
Cancer biomarkers market for TMB, MSI / MMR and TILs is estimated to be worth USD 860 million in 2030, predicts Roots Analysis
A detailed analysis of ongoing, biomarker-based clinical trials initiated by big pharmaceutical companies.
January 27, 2021
The “Neoantigen Targeted Therapies Market, 2019-2030”
An analysis of the investments made, including seed financing, venture capital financing
January 25, 2021
Presently, over 150 neoantigen targeted therapies are being evaluated for advanced cancer indications
Several therapy candidates are being investigated both as monotherapies and in combination
January 25, 2021